Shock Wave Therapy + Local Vibration Beneficial for Chronic Plantar Fasciitis
2024-01-30
临床结果
TUESDAY, Jan. 30, 2024 -- For patients with chronic plantar fasciitis, extracorporeal shock wave therapy combined with local vibration (ESWT-LV) is effective compared with ESWT alone, according to a study recently published in the Journal of Rehabilitation Medicine.
HyoJeong On and JongEun Yim, D.Sc., from the Graduate School of Sahmyook University in Seoul, South Korea, conducted a trial involving 34 patients (mean age, 37.5 years) with chronic plantar fasciitis who were randomly assigned to treatment with ESWT-LV or with ESWT alone. In each group, participants underwent two treatment sessions weekly for five weeks.
The researchers found that in both groups, there were significant improvements in the thickness of the plantar fascia, numerical rating scale for pain, and Foot Function Index values. Significantly greater decreases were seen in the thickness of the plantar fascia and pain in the ESWT-LV versus the ESWT-alone group. Foot Function Index values did not differ significantly between the groups.
"Based on these results, LV can be considered an effective adjunct to ESWT for plantar fasciitis," the authors write. "Further studies are necessary to determine the best parameters for LV combined with ESWT treatment in muscular skeletal disorders, in order to establish a treatment protocol."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Posted January 2024
More news resources
FDA Medwatch Drug Alerts
Daily MedNews
News for Health Professionals
New Drug Approvals
New Drug Applications
Drug Shortages
Clinical Trial Results
Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
靶点
-药物
-热门报告
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。